By Justin Petrone

Baylor College of Medicine's Human Genome Sequencing Center has standardized its target-enrichment human disease research studies on Roche NimbleGen Sequence Capture Exome technology, Roche said this week.

Baylor plans to sequence more than 5,000 exomes in the next two years to identify genetic variants underlying multiple human diseases. The center will use NimbleGen's SeqCap EZ Exome and customized NimbleGen exome designs as its exome-capture technology of choice, according the firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.